VCAM-1 and NrCAM were identified as gelatinase substrates at the astroglial border that were up-regulated during neuroinflammation, when barrier function is compromised, and were also detected in the CSF of patients with multiple sclerosis, suggesting relevance to changes in human BBB functional integrity. The gene discussed is NRCAM; the disease is multiple sclerosis.